Viewing SEC Facts Units
Company Name:
Poseida Therapeutics, Inc.
CIK:
1661460
Start Filing Date:
2022-01-01
End Filing Date:
2022-09-30
ACCN:
0001564590-22-037398
Value:
$ 75,299,000
Value Error:
$ None
Created By:
Date Filed:
2022-11-10
FY:
2022
Fiscal Period:
Q3
Frame:
CY2021Q3
Type:
us-gaap
Form:
10-Q
Units:
USD